Dar es Salaam. Health practitioners in Tanzania are optimistic after the official registration of Lenacapavir, a long-acting injectable drug for HIV prevention and treatment, a move seen as a major step forward in the fight against the virus.
Chief Government Pharmacist, Mr Daud Msasi, announced on 24 February 2026 that the drug had been registered by the Tanzania Medicines and Medical Devices Authority (TMDA) and incorporated into national HIV treatment guidelines.
